Trichomoniasis refractory to 5-nitroimidazole therapy in Trinidad

Trop Doct. 2023 Jan;53(1):143-145. doi: 10.1177/00494755221131370. Epub 2022 Oct 9.

Abstract

Trichomoniasis is the most common non-viral sexually transmitted infection (STI) occurring worldwide and the majority of infected persons (70-85%) have mild or no genital symptoms. Symptoms in women may include a vaginal discharge which may be associated with vulval irritation and most infections can be effectively treated with metronidazole 500mg bd for seven days. Trichomoniasis unresponsive to 5-nitroimidazole therapy is uncommon but results in substantial therapeutic challenges, especially in resource limited countries. We present such a case which was eventually treated with a low-cost intravaginal combination of boric acid and clotrimazole cream.

Keywords: 5-nitroimidazole; Trichomoniasis; boric acid; clotrimazole; refractory.

MeSH terms

  • Female
  • Humans
  • Metronidazole / therapeutic use
  • Trichomonas Infections*
  • Trichomonas Vaginitis* / diagnosis
  • Trichomonas Vaginitis* / drug therapy
  • Trinidad and Tobago

Substances

  • 4-nitroimidazole
  • Metronidazole